首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Andrographolide and 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata attenuate high glucose-induced fibrosis and apoptosis in murine renal mesangeal cell lines.
【24h】

Andrographolide and 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata attenuate high glucose-induced fibrosis and apoptosis in murine renal mesangeal cell lines.

机译:来自穿心莲的穿心莲内酯和14-脱氧-11,12-二氢脱水穿心莲内酯可减轻高糖诱导的小鼠肾系膜细胞系的纤维化和细胞凋亡。

获取原文
获取原文并翻译 | 示例
       

摘要

ETHNOPHARMACOLOGICAL RELEVANCE: Extracts of Andrographis paniculata Nees are used for various ethnomedical conditions including hyperglycemia and hypertension complications. AIM OF THE STUDY: The purpose of this study is to evaluate the anti-diabetic nephropathy effect of diterpene lactones andrographolide (AP1) and 14-deoxy-11,12-didehydroandrographolide (AP2) from Andrographis paniculata. MATERIALS AND METHODS: MES-13, a SV40-transformed murine glomerular mesangial cell line, was cultured in high concentration of glucose to induce diabetic nephropathy phenotypes, which include secretion of extracellular matrix protein fibronectin, cytokine TGF-beta, states of oxidative stress, and apoptosis marker caspase-3. RESULTS: Our data suggest that addition of compounds AP1 or AP2 reduces the phenotypes indicating diabetic nephropathy in MES-13 cells. The compound AP2 showed potent activity than AP1 in the reduction of apoptosis marker caspase-3, fibrosis marker TGF-beta, and PAI-1. Furthermore, AP1 and AP2 do not have antioxidant ability in acellular environment; however, addition of AP1 and AP2 reduced intracellular oxidative states in high glucose cultured MES-13 cells. CONCLUSION: This is the first report on anti-diabetic nephropathy effect of AP1 and AP2 in part due to the regulation of intracellular signaling transduction, not mere clearance of reactive oxygen species. Thus, this study may be useful for drug development or food supplement for diabetes and nephropathy from Andrographis paniculata.
机译:人种药理关系:穿心莲提取物可用于多种人种学条件,包括高血糖症和高血压并发症。研究目的:本研究的目的是评估穿心莲中二萜内酯穿心莲内酯(AP1)和14-脱氧-11,12-二氢-穿心莲内酯(AP2)的抗糖尿病肾病作用。材料与方法:MES-13是SV40转化的鼠肾小球系膜细胞系,在高浓度葡萄糖中培养以诱导糖尿病性肾病表型,包括细胞外基质蛋白纤连蛋白的分泌,细胞因子TGF-β,氧化应激状态,和凋亡标记caspase-3。结果:我们的数据表明,化合物AP1或AP2的添加会降低表明MES-13细胞中糖尿病性肾病的表型。化合物AP2在减少凋亡标志物caspase-3,纤维化标志物TGF-beta和PAI-1方面显示出比AP1更强的活性。此外,AP1和AP2在无细胞环境中不具有抗氧化能力;然而,在高葡萄糖培养的MES-13细胞中,添加AP1和AP2会降低细胞内的氧化状态。结论:这是关于AP1和AP2抗糖尿病肾病作用的第一份报道,部分原因是调节细胞内信号转导,而不仅仅是清除活性氧。因此,该研究可能对穿心莲的糖尿病和肾病的药物开发或食品补充有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号